{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"6"},{"groupId":"OG007","value":"1"},{"groupId":"OG008","value":"14"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"6"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"9"},{"groupId":"OG007","value":"5"},{"groupId":"OG008","value":"21"}],"units":"Participants"}],"groups":[{"description":"Part A Dose Level 1 NM21-1480-Q2W 0.15mg","id":"OG000","title":"Part A Dose Level 1 NM21-1480-Q2W 0.15mg"},{"description":"Part A Dose Level 2 NM21-1480-Q2W 1.5mg","id":"OG001","title":"Part A Dose Level 2 NM21-1480-Q2W 1.5mg"},{"description":"Part A Dose Level 3 NM21-1480-Q2W 8mg","id":"OG002","title":"Part A Dose Level 3 NM21-1480-Q2W 8mg"},{"description":"Part A Dose Level 4 NM21-1480-Q2W 24mg","id":"OG003","title":"Part A Dose Level 4 NM21-1480-Q2W 24mg"},{"description":"Part A Dose Level 5 NM21-1480-Q2W 80mg","id":"OG004","title":"Part A Dose Level 5 NM21-1480-Q2W 80mg"},{"description":"Part A Dose Level 6 NM21-1480-Q2W 240mg","id":"OG005","title":"Part A Dose Level 6 NM21-1480-Q2W 240mg"},{"description":"Part A Dose Level 7 NM21-1480-Q2W 800mg","id":"OG006","title":"Part A Dose Level 7 NM21-1480-Q2W 800mg"},{"description":"Part A2 NM21-1480-Q2W 1400mg","id":"OG007","title":"Part A2 NM21-1480-Q2W 1400mg"},{"description":"Part B NM21-1480-Q2W 800mg","id":"OG008","title":"Part B NM21-1480-Q2W 800mg"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"A patient is considered positive if they are positive at any scheduled or unscheduled post-baseline assessment.","reportingStatus":"POSTED","timeFrame":"From baseline to up to 12 weeks post last dose, up to 48 weeks.","title":"Assessment of the Frequency of Specific Anti-drug Antibodies to NM21-1480","type":"SECONDARY","unitOfMeasure":"Participants"}